Background In Human immunodeficiency virus (HIV)-positive patients undergoing kidney transplantation, outcomes and immunosuppression (IS) protocol are not yet established due to infectious and neoplastic risks as well as to pharmacokinetic interactions with antiretroviral therapy (TARV). Methods We report a retrospective, 1-center study on 18 HIV+ patients undergoing, between October 2007 and September 2015, kidney transplantation (13 cases) or combined kidney-liver transplant (5 cases). Inclusion criteria for transplant were based on the Italian National Transplant Center protocol. IS regimen was based on quick tapering of steroids and the use of mTOR inhibitors (mTORi) with low dose of calcineurin inhibitors (CNI). In the early post-transplant period, TARV was based on enfuvirtide, raltegravir, plus 1 or more nucleoside analogues. Results In a mean follow-up of 3.1 years, patient survival rate at 1 and 3 years was, respectively, 86.6% and 84.6%, whereas graft survival was 81.2% and 78.6%. Cumulative rejection rate was 20.0% and 26.6% (1- and 3-year results). Median eGFR (MDRD) was 58.8 mL/min and 51.9 mL/min at 1 and 3 years. We had 9 cases of clinically relevant infections (2 Pneumocystis jirovecii pneumonia, 1 pulmonary aspergillosis, 2 severe sepsis, and 4 HCV reactivation) as well as 1 case (5.5%) of HIV reactivation. Conclusions IS therapy based on mTORi and low CNI dose ensures good graft survival, low rate of acute rejection, limited drug toxicity, and control of HIV disease. TARV has no significant interaction with IS therapy.
|Data di pubblicazione:||2016|
|Titolo:||Kidney Transplantation in HIV-Infected Recipients: Therapeutic Strategy and Outcomes in Monocentric Experience|
|Autore/i:||Baisi, Alberto; Nava, F.; Baisi, B.; Rubbiani, E.; Guaraldi, Giovanni; DI BENEDETTO, Fabrizio; Giovannoni, M.; Solazzo, A.; Bonucchi, D.; Cappelli, Gianni|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.transproceed.2015.12.038|
|Codice identificativo ISI:||WOS:000375240300012|
|Codice identificativo Scopus:||2-s2.0-84964426664|
|Codice identificativo Pubmed:||27109949|
|Citazione:||Kidney Transplantation in HIV-Infected Recipients: Therapeutic Strategy and Outcomes in Monocentric Experience / Baisi, Alberto; Nava, F.; Baisi, B.; Rubbiani, E.; Guaraldi, Giovanni; DI BENEDETTO, Fabrizio; Giovannoni, M.; Solazzo, A.; Bonucchi, D.; Cappelli, Gianni. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - 48(2016), pp. 333-336.|
|Tipologia||Articolo su rivista|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris